|
⚲
|
| Keyboard |
| Finck Barbara K
✚
|
|
|---|---|
| CIK # | 0001242116 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001242116] | |
| 4 | [0001242116] | |
| 5 | [0001242116] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tocagen Inc | |
| Finck Barbara K | |
| Comera Life Sciences Holdings Inc | |
| Coherus Oncology Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2025-03-19 | Grant | 31,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2024-08-20 | Grant | 50,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2024-03-21 | Grant | 175,000 | $0.00 | |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2023-09-19 | Grant | 25,000 | $0.00 | |
|
Comera Life Sciences Holdings Inc CMRA
Warrants (right to buy) · derivative
|
2023-01-04 | Grant | 6,756 | $0.25 | 1,689 |
|
Comera Life Sciences Holdings Inc CMRA
Common Stock
|
2023-01-04 | Grant | 6,756 | $1.23 | 8,310 |
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2022-06-01 | Grant | 25,000 | $0.00 | |
|
Comera Life Sciences Holdings Inc CMRA
Stock Option (Right to Buy) · derivative
|
2022-05-19 | Grant | 37,111 | ||
|
Tocagen Inc FBRX
Stock Option (right to buy) · derivative
|
2022-03-16 | Grant | 50,000 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-09-10 | Option exercise | 1,760 | $1.42 | 2,499 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-09-10 | Sell | 1,760 | $18.58 | 32,701 |
|
Coherus Oncology Inc CHRS
Stock Option (right to buy) · derivative
|
2018-09-10 | Option exercise | 1,760 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-08-13 | Sell | 1,760 | $19.02 | 33,475 |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-08-13 | Option exercise | 1,760 | $1.42 | 2,499 |
|
Coherus Oncology Inc CHRS
Stock Option (right to buy) · derivative
|
2018-08-13 | Option exercise | 1,760 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-07-10 | Option exercise | 1,260 | $1.42 | 1,789 |
|
Coherus Oncology Inc CHRS
Stock Option (right to buy) · derivative
|
2018-07-10 | Option exercise | 1,260 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-07-10 | Sell | 1,260 | $15.00 | 18,900 |
|
Coherus Oncology Inc CHRS
Stock Option (right to buy) · derivative
|
2018-07-09 | Option exercise | 500 | $0.00 | |
|
Coherus Oncology Inc CHRS
Common Stock, $0.0001 par value
|
2018-07-09 | Option exercise | 500 | $1.42 | 710 |
| showing 20 of 33 most recent transactions | |||||